Showing 3,761 - 3,780 results of 8,849 for search 'significant ((((((teer decrease) OR (greatest decrease))) OR (we decrease))) OR (mean decrease))', query time: 0.53s Refine Results
  1. 3761

    DataSheet1_Chronic exposure to inhaled vaporized cannabis high in THC suppresses Adderall-induced brain activity.zip by Jack M. Ognibene (19830132)

    Published 2024
    “…In this exploratory study we hypothesized chronic exposure to Δ9-THC through vaporized cannabis would diminish the CNS activity of Adderall.…”
  2. 3762

    Data Sheet 1_Genomic and immune profiling of prognostic risk groups in IgM gammopathy reveals novel biomarkers beyond MYD88 L265P.docx by David F. Moreno (5597948)

    Published 2025
    “…Regarding the mRNA expression analyses, we found an increased proportion of myeloid cells in the low-risk group, with monocytes having a significant decrease in low versus high-risk patients. …”
  3. 3763

    Table 3_NK cells-derived extracellular vesicles potency in the B cell lymphoma biotherapy.docx by Serena Cecchetti (396031)

    Published 2024
    “…In vivo results showed metabolic alterations in SCID mice xenografts after NKEV treatment, associated with a significant reduction of tumor growth (64%). In the in vivo<sup>1</sup>H MR spectra we found a significant increase in the tumor lipid/lactate and in taurine signals, both considered as apotosis markers. …”
  4. 3764

    Table 4_NK cells-derived extracellular vesicles potency in the B cell lymphoma biotherapy.docx by Serena Cecchetti (396031)

    Published 2024
    “…In vivo results showed metabolic alterations in SCID mice xenografts after NKEV treatment, associated with a significant reduction of tumor growth (64%). In the in vivo<sup>1</sup>H MR spectra we found a significant increase in the tumor lipid/lactate and in taurine signals, both considered as apotosis markers. …”
  5. 3765

    Table 1_NK cells-derived extracellular vesicles potency in the B cell lymphoma biotherapy.docx by Serena Cecchetti (396031)

    Published 2024
    “…In vivo results showed metabolic alterations in SCID mice xenografts after NKEV treatment, associated with a significant reduction of tumor growth (64%). In the in vivo<sup>1</sup>H MR spectra we found a significant increase in the tumor lipid/lactate and in taurine signals, both considered as apotosis markers. …”
  6. 3766

    Image 3_NK cells-derived extracellular vesicles potency in the B cell lymphoma biotherapy.tif by Serena Cecchetti (396031)

    Published 2024
    “…In vivo results showed metabolic alterations in SCID mice xenografts after NKEV treatment, associated with a significant reduction of tumor growth (64%). In the in vivo<sup>1</sup>H MR spectra we found a significant increase in the tumor lipid/lactate and in taurine signals, both considered as apotosis markers. …”
  7. 3767

    Image 1_NK cells-derived extracellular vesicles potency in the B cell lymphoma biotherapy.tif by Serena Cecchetti (396031)

    Published 2024
    “…In vivo results showed metabolic alterations in SCID mice xenografts after NKEV treatment, associated with a significant reduction of tumor growth (64%). In the in vivo<sup>1</sup>H MR spectra we found a significant increase in the tumor lipid/lactate and in taurine signals, both considered as apotosis markers. …”
  8. 3768

    Table 2_NK cells-derived extracellular vesicles potency in the B cell lymphoma biotherapy.docx by Serena Cecchetti (396031)

    Published 2024
    “…In vivo results showed metabolic alterations in SCID mice xenografts after NKEV treatment, associated with a significant reduction of tumor growth (64%). In the in vivo<sup>1</sup>H MR spectra we found a significant increase in the tumor lipid/lactate and in taurine signals, both considered as apotosis markers. …”
  9. 3769

    Image 2_NK cells-derived extracellular vesicles potency in the B cell lymphoma biotherapy.tif by Serena Cecchetti (396031)

    Published 2024
    “…In vivo results showed metabolic alterations in SCID mice xenografts after NKEV treatment, associated with a significant reduction of tumor growth (64%). In the in vivo<sup>1</sup>H MR spectra we found a significant increase in the tumor lipid/lactate and in taurine signals, both considered as apotosis markers. …”
  10. 3770

    Data Sheet 1_Understanding mechanistic relationships between IgG titers and Fc effector functions: a computational framework to assess polyfunctionality.docx by Suzanne K. Shoffner-Beck (22253548)

    Published 2025
    “…Surprisingly, simulated boosting of IgG3 alone had the potential to significantly decrease ADCP (p<0.00001), though it would increase ADCC responses. …”
  11. 3771

    Development of binaural auditory brainstem physiology. by Kelsey L. Anbuhl (22190594)

    Published 2025
    “…BIC DN1 latency at 0 µs ITD decreased significantly with age, as confirmed by Spearman’s rho (<i>p</i> = 0.000); an exponential decay function was fit to the data (red line). …”
  12. 3772

    DataSheet1_The impact of statin use on short-term and long-term mortality in patients with heart failure.docx by Xiaoxue Zheng (433886)

    Published 2024
    “…Rosuvastatin was associated with the greatest reduction of all-cause mortality rates. Low-dose statins can significantly reduce short-term and long-term mortality, while high-dose statins are not significantly correlated with mortality. …”
  13. 3773

    Supplementary Material for: Forecasting the Worldwide Impact of Stroke for individuals aged 45 and above by Fan W. (11417327)

    Published 2024
    “…Background:We aimed to assess the global impact of stroke in people aged 45 years and older between 1990 and 2030, focusing on morbidity, mortality and disability-adjusted life years (DALYs). …”
  14. 3774

    TgHCF101 is involved in Fe-S cluster biogenesis of the CIA pathway. by Eléa A. Renaud (18192764)

    Published 2025
    “…Values are represented as the mean ± SD from <i>n</i> = 4 independent biological replicates, ** <i>p</i>-value ≤0.01, **** <i>p</i>-value ≤0.0001; ns, not significant (<i>p</i>-value ≥0.05), Student’s <i>t</i> test. …”
  15. 3775

    EG-specific MMP-1 RNAi does not block glial infiltration or pruning. by Vanessa Kay Miller (19775496)

    Published 2025
    “…All data points with mean ± SEM. Significance indicated as <i>p</i> < 0.0001 (****). …”
  16. 3776

    Table 1_Impacts of surface wear of attachments on maxillary canine distalization with clear aligners: a three-dimensional finite element study.docx by Qiuying Li (565107)

    Published 2025
    “…In the optimized root control attachment group, the greatest reduction was observed in M4–M6, and the efficiency of canine distalization decreased to less than 60% in response to M6.…”
  17. 3777

    OVX educes bone density of femur. by Mingzhu Chen (6370013)

    Published 2025
    “…Compared to Sham rats, OVX tats had a significant decrease in bone mass and impaired bone micro structure: (L) BMD, (M) BV, (N) BV/TV, (O) Tb.N,(P) Tb.Sp, and (Q) Tb.Th. …”
  18. 3778

    Elf5 can regulate colony forming abilities of epidermal and hair follicle stem cells. by Anhua Hu (4805145)

    Published 2025
    “…(<b>c,f</b>) Quantification of colonies formed after modulation of Elf5 functions in epidermal SCs leads to a significant reduction in size (>100μm, shElf5). In addition, significant decrease in total number of colonies being formed after loss and gain of Elf5 functions compared with control SCs. …”
  19. 3779

    Data Sheet 1_Global trends and future predictions of gastrointestinal ulcers in youth.pdf by Kun He (178646)

    Published 2025
    “…The ARIMA model, identified as the most accurate prediction model, suggests that by 2050, the burden of gastrointestinal ulcers in this age group will significantly decrease compared to 2019. Over the next 30 years, the global number of incident cases will initially rise before stabilizing, prevalent cases will fluctuate, and both DALYs and deaths will decline. …”
  20. 3780

    Efficacy of Low-Dose Naltrexone in Treating Patients with Fibromyalgia: systematic Review and Meta-Analysis by Abiodun Ologunowa (21343002)

    Published 2025
    “…In the LDN group, the Standardized Mean Difference (SMD) for pain decreased by 1.03 (95% confidence interval (CI): −1.25, −0.80; I<sup>2</sup> = 25%), and fibromyalgia symptom severity decreased by 1.02 (95% CI: −1.35, −0.69; I<sup>2</sup> = 52%) post-LDN treatment compared to the baseline. …”